These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37949940)

  • 1. Mannich-type modifications of (-)-cannabidiol and (-)-cannabigerol leading to new, bioactive derivatives.
    Lőrincz EB; Tóth G; Spolárics J; Herczeg M; Hodek J; Zupkó I; Minorics R; Ádám D; Oláh A; Zouboulis CC; Weber J; Nagy L; Ostorházi E; Bácskay I; Borbás A; Herczegh P; Bereczki I
    Sci Rep; 2023 Nov; 13(1):19618. PubMed ID: 37949940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination.
    Robaina Cabrera CL; Keir-Rudman S; Horniman N; Clarkson N; Page C
    Pulm Pharmacol Ther; 2021 Aug; 69():102047. PubMed ID: 34082108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties.
    Perez E; Fernandez JR; Fitzgerald C; Rouzard K; Tamura M; Savile C
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews.
    Rock EM; Goodwin JM; Limebeer CL; Breuer A; Pertwee RG; Mechoulam R; Parker LA
    Psychopharmacology (Berl); 2011 Jun; 215(3):505-12. PubMed ID: 21243485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol and Cannabigerol Exert Antimicrobial Activity without Compromising Skin Microbiota.
    Luz-Veiga M; Amorim M; Pinto-Ribeiro I; Oliveira ALS; Silva S; Pimentel LL; Rodríguez-Alcalá LM; Madureira R; Pintado M; Azevedo-Silva J; Fernandes J
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways.
    Viereckl MJ; Krutsinger K; Apawu A; Gu J; Cardona B; Barratt D; Han Y
    Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Origin and Biomedical Relevance of Cannabigerol.
    Jastrząb A; Jarocka-Karpowicz I; Skrzydlewska E
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
    Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety assessment and redox status in rats after chronic exposure to cannabidiol and cannabigerol.
    Polanska HH; Petrlakova K; Papouskova B; Hendrych M; Samadian A; Storch J; Babula P; Masarik M; Vacek J
    Toxicology; 2023 Apr; 488():153460. PubMed ID: 36796712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressure.
    Szczesniak AM; Maor Y; Robertson H; Hung O; Kelly ME
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):427-35. PubMed ID: 21770780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant function of phytocannabinoids: Molecular basis of their stability and cytoprotective properties under UV-irradiation.
    Vacek J; Vostalova J; Papouskova B; Skarupova D; Kos M; Kabelac M; Storch J
    Free Radic Biol Med; 2021 Feb; 164():258-270. PubMed ID: 33453360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol.
    Linciano P; Citti C; Russo F; Tolomeo F; Laganà A; Capriotti AL; Luongo L; Iannotta M; Belardo C; Maione S; Forni F; Vandelli MA; Gigli G; Cannazza G
    Sci Rep; 2020 Dec; 10(1):22019. PubMed ID: 33328530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se.
    Hill AJ; Jones NA; Smith I; Hill CL; Williams CM; Stephens GJ; Whalley BJ
    Neurosci Lett; 2014 Apr; 566():269-74. PubMed ID: 24642454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol.
    Mammana S; Cavalli E; Gugliandolo A; Silvestro S; Pollastro F; Bramanti P; Mazzon E
    Medicina (Kaunas); 2019 Nov; 55(11):. PubMed ID: 31752240
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour.
    Deiana S; Watanabe A; Yamasaki Y; Amada N; Arthur M; Fleming S; Woodcock H; Dorward P; Pigliacampo B; Close S; Platt B; Riedel G
    Psychopharmacology (Berl); 2012 Feb; 219(3):859-73. PubMed ID: 21796370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pharmacological Case for Cannabigerol.
    Nachnani R; Raup-Konsavage WM; Vrana KE
    J Pharmacol Exp Ther; 2021 Feb; 376(2):204-212. PubMed ID: 33168643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antinociceptive activity and mechanism of action of cannabigerol.
    Wen Y; Wang Z; Zhang R; Zhu Y; Lin G; Li R; Zhang J
    Biomed Pharmacother; 2023 Feb; 158():114163. PubMed ID: 36916438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidiol and Cannabigerol Modify the Composition and Physicochemical Properties of Keratinocyte Membranes Exposed to UVA.
    Wroński A; Dobrzyńska I; Sękowski S; Łuczaj W; Olchowik-Grabarek E; Skrzydlewska E
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT
    Echeverry C; Prunell G; Narbondo C; de Medina VS; Nadal X; Reyes-Parada M; Scorza C
    Neurotox Res; 2021 Apr; 39(2):335-348. PubMed ID: 32886342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of aldose reductase activity by Cannabis sativa chemotypes extracts with high content of cannabidiol or cannabigerol.
    Smeriglio A; Giofrè SV; Galati EM; Monforte MT; Cicero N; D'Angelo V; Grassi G; Circosta C
    Fitoterapia; 2018 Jun; 127():101-108. PubMed ID: 29427593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.